| First Author | Véniant MM | Year | 1999 |
| Journal | J Nutr | Volume | 129 |
| Issue | 2S Suppl | Pages | 451S-455S |
| PubMed ID | 10064308 | Mgi Jnum | J:53752 |
| Mgi Id | MGI:1333370 | Doi | 10.1093/jn/129.2.451S |
| Citation | Veniant MM, et al. (1999) Insights into apolipoprotein B biology from transgenic and gene-targeted mice. J Nutr 129(2S Suppl):451S-455S |
| abstractText | Over the past five years, several laboratories have used transgenic and gene-targeted mice to study apolipoprotein (apo) B biology. Genetically modified mice have proven useful for investigating the genetic and environmental factors affecting atherogenesis, for defining apoB structure/function relationships, for understanding the regulation of the apoB gene expression in the intestine, for defining the ''physiologic rationale'' for the existence of the two different forms of apoB (apoB48 and apoB100) in mammalian metabolism and for providing mechanistic insights into the human apoB deficiency syndrome, familial hypobetalipoproteinemia. This review will provide several examples of how genetically modified mice have contributed to our understanding of apoB biology, including our new discovery that human heart myocytes secrete nascent apoB-containing lipoproteins. |
